During the 2025 San Antonio Breast Cancer Symposium (SABCS), I had the privilege of participating a panel discussion that was a collaboration between the Alamo Breast Cancer Foundation, the Metastatic Breast Cancer Alliance (MBCA), the American Association of Clinical Research (AACR) and the Advanced Breast Cancer Global Alliance (ABCGA). Dr Fatima Cordoso and Teri Pollastro were the moderators, Dr. Mariana Chavez MacGregor from MD Anderson was the keynote speaker, and in addition to myself, Kirstin Spencer from METUPUK was a panelist. The title of our discussion was, in part, Demystifying Clinical Trials.

Time for this week’s round-up of the best of the blog posts which I’ve read over the past week. These are the posts that have moved me, taught me … Weekly Round-Up

When we add up all of the chaos, only exacerbated by the perpetual news cycle, the burden of trying to find truth when no one gives us everything, it is entirely reasonable to feel paralyzed, to feel as though all hope is lost, to not know where to turn. Whenever I turn on the news, I am bombarded by the different events, by rhetoric and opinions, by shocking videos, by big changes to systems we rely upon. It feels so big, it feels so chaotic, it feels overwhelming. I find it hard to look away, I find it hard to keep looking.

Black women are facing a systemic gynecological health crisis. This book gives them the tools needed to unlearn the medical normalization of their suffering and offers a path forward to healing—by...

An analysis from the World Health Organization (WHO) Global Advisory Committee on Vaccine Safety (GACVS) concluded that there is no causal link between vaccines and autism spectrum disorder, according...

In this clumsy metaphor, the doors and windows are treatment options for Stage IV Metastatic Breast Cancer (MBC) and so many of us only have a finite number of treatments before this terminal diagnosis completes its trajectory and ends its own existence and the host. Reaching the end of a treatment option and contemplating the shorter and shorter list of what could be next has occupied my thoughts and triggered a deluge of new and familiar angst in the last few months. But let me take two steps back and mention a new wrinkle in the cancer experience for me — a new primary cancer.

Thankful to Marie at Journeying Beyond Breast Cancer for gathering up amazing blogs every single week and sharing her weekly round up. Sharing here so you can learn more about the various bloggers she brings together week after week — each of them is worth a follow! Warmly, Abigail

2025 was a bit of a dumpster fire in relation to my medical care. It is only now looking back on the previous 12 months that I can begin to see just how bad it really was. It wasn’t just the specific side effects of Enhertu that put me into a foggy state most of the time, but also how many new and complicated things I had to manage. The year started off relatively typically in this Stage IV Metastatic Breast Cancer (MBC) experience in that it was full of appointments and side effects from the Antibody Drug Conjugate (ADC) I was on, Enhertu.

Entering 2026, the author reminisces about words selected previously and announces her word for 2026.

A Department of Veterans Affairs memo obtained by ProPublica erects new roadblocks to care for veterans with the rare but deadly cancer. The agency cites no new science but relies on an executive orde...

A podcast providing insights, stories, and support for metastatic breast cancer patients and advocates. Join us to stay informed and empowered.

Dr. Chino welcomes Dr. Vivek Patel and Dr. Eleonora Teplinsky to discuss a recent article in JCO OP that reported a podcast-based curriculum could improve knowledge and comfort with common education t...

This is a free, educational event for patients with metastatic breast cancer & their caregivers hosted by Fred Hutch.

Good morning! Picking up where I left off last week with Breast Cancer Awareness month educational tiles from Metavivor: In 2017, I was 38 and had never had a mammogram because I did not yet meet the criteria for screening. I received my first mammogram in the process of my de novo diagnosis and if I had been getting mammograms, the density of my breast tissue and the fact I was breastfeeding would have affected the results. Every person needs to know their individual risk and which screening and diagnostic testing is the best for their body.

Dr. Cassann Blake, a breast surgical oncologist at the Cleveland Clinic, on lobular breast cancer.